Traumatic brain injury-related ferroptosis: current perspectives
Journal of Molecular Medicine · 2026-12 · 104 (1)
DOI: 10.1007/s00109-025-02620-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Molecular Medicine, online erschienen am 15.12.2025. Verfasst von Rongkun Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Yangpu Hospital, School of Medicine, Tongji University, Shanghai, 200090, China. Hauptthemen laut MEDLINE: Ferroptosis, Brain Injuries, Traumatic. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 143 Literaturangaben.
Abstract (Originalsprache)
Traumatic brain injury (TBI) is a leading cause of mortality and long-term disability worldwide, with secondary injuries amplifying neuronal damage through mechanisms such as ferroptosis-a regulated iron-dependent cell death driven by lipid peroxidation. This review synthesizes current evidence on ferroptosis in TBI, highlighting its core pathways: (1) iron metabolism dysregulation (e.g., TfR1 upregulation, ferritin suppression), (2) lipid peroxidation (mediated by ACSL4/LPCAT3/PUFA oxidation), and (3) glutathione depletion (via System Xc-/GSH/GPX4 axis disruption). Ferroptosis intersects with mitochondrial dysfunction, ER stress, and neuroinflammation, exacerbating neuronal death. The hippocampus, vulnerable to post-TBI damage, shows elevated ferroptosis markers (e.g., Tyro3, NRF2/p53 pathways). Iron chelators (e.g., deferoxamine), antioxidants (e.g., ferrostatin-1, liproxstatin-1), and natural compounds (e.g., melatonin, trehalose) demonstrate neuroprotection by mitigating oxidative stress and restoring metabolic balance. Emerging approaches include ncRNA therapies (e.g., miR-212-5p) and stem cell interventions targeting ferroptosis-related genes. Despite progress, key gaps persist in understanding ferroptosis crosstalk with apoptosis/pyroptosis, optimizing drug delivery (e.g., nanoparticle carriers), and validating biomarkers for clinical translation. Targeting ferroptosis offers a promising avenue for TBI treatment, but further research is needed to refine therapeutic specificity and integrate these strategies into clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Yangpu Hospital, School of Medicine, Tongji University, Shanghai, 200090, China.
- Department of Emergency Surgery, Guizhou Provincial People's Hospital, Guiyang, 550002, China.
- Department of Emergency Surgery, Guizhou Provincial People's Hospital, Guiyang, 550002, China. Liufashun1221@163.com.
Zitieren
APA
Zhu, R., Pan, J., Min, Y., Wang, H., Zhang, J., & Liu, F. (2026). Traumatic brain injury-related ferroptosis: current perspectives. Journal of Molecular Medicine, 104(1). https://doi.org/10.1007/s00109-025-02620-2
Vancouver
Zhu R, Pan J, Min Y, Wang H, Zhang J, Liu F. Traumatic brain injury-related ferroptosis: current perspectives. Journal of Molecular Medicine. 2026;104(1). doi:10.1007/s00109-025-02620-2
BibTeX
@article{Zhu2026,
author = {Zhu, Rongkun and Pan, Jizhou and Min, Yucong and Wang, Hao and Zhang, JianKang and Liu, Fashun},
title = {Traumatic brain injury-related ferroptosis: current perspectives},
journal = {Journal of Molecular Medicine},
year = {2026},
volume = {104},
number = {1},
doi = {10.1007/s00109-025-02620-2}
}
EUVIMED